Lifetech Scientific
14F, LifeTech Scientific Building, Keji 12th Road South, High-tech Industrial Park, Nanshan District, Shenzhen, Guangdong, 518063, China
Overview
Lifetech is a leading developer, manufacturer and vendor of advanced minimally invasive medical devices for cardiovascular and peripheral vascular diseases and disorders. Lifetech was founded in 1999 and is now the second largest provider of congenital heart defect occluders in the world, the largest provider to BRIC countries and the leading developer and manufacturer of minimally invasive medical devices in China. In 2011, Lifetech was listed on the Hong Kong Stock Exchange. Lifetech has a broad portfolio of proprietary, minimally invasive cardiovascular and peripheral medical devices.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 2
Sector focus
- Health Care
- Manufacturing
- Medical
- Medical Device
Investment portfolio
- Grail
Participated · Series C · May 2018
Grail develops Galleri, a blood-based multi-cancer early detection test intended to detect multiple cancers from a single blood draw. The company received a $110 million equity investment from Samsung affiliates to support its plans. The reported use of funds is for international expansion of Galleri and to accelerate market adoption. The article does not provide operating metrics such as revenue or user counts. No details on prior funding rounds, valuation, founding year, or company location were included in the source. The coverage focused on the capital raise and its intended use rather than operational metrics.
Team
Xie Yuehui
Executive Director & Chief Executive Officer
Liu Jianxiong
Executive Director, Vice President and Chief Financial Officer and Company Secretary